Abstract
133P - A study evaluating the different treatment modalities for EGFR mutation positive advanced NSCLC patients that acquire c-MET amplification after EGFR TKI therapy resistant
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have